Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1D known ✓ | P28221 | 2/20 | 0.62 |
| ▸ | ADRA2C known ✓ | P18825 | 13/20 | 0.60 |
| ▸ | ADRA2A known ✓ | P08913 | 12/20 | 0.60 |
| ▸ | ADRA2B known ✓ | P18089 | 12/20 | 0.60 |
| ▸ | ADRA1A known ✓ | P35348 | 4/20 | 0.60 |
| ▸ | ADRA1D known ✓ | P25100 | 3/20 | 0.60 |
| ▸ | ADRA1B known ✓ | P35368 | 3/20 | 0.60 |
| ▸ | HTR2A known ✓ | P28223 | 1/20 | 0.60 |
| ▸ | HTR2C known ✓ | P28335 | 1/20 | 0.60 |
| ▸ | HTR7 known ✓ | P34969 | 1/20 | 0.60 |
| ▸ | HTR1A known ✓ | P08908 | 1/20 | 0.58 |
| ▸ | HRH2 known ✓ | P25021 | 1/20 | 0.58 |
| ▸ | OPRK1 known ✓ | P41145 | 1/20 | 0.58 |
| ▸ | CFB known ✓ | P00751 | 2/20 | 0.48 |
| ▸ | HTR1B known ✓ | P28222 | 1/20 | 0.48 |
| ▸ | KCNH2 known ✓ | Q12809 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.60 |
| ▸ | BLM | P54132 | 3/20 | 0.60 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.60 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4762027 | 0.98 | HTR1D (0.64) | HTR1DADRA2CADRA2AADRA2BADRA1A | |
| SCHEMBL4761139 | 0.90 | HTR1D (0.75) | HTR1DADRA2CADRA2AADRA2BADRA1A | |
| SCHEMBL9069376 | 0.80 | CFB (0.51) | HTR1DADRA2CADRA2AADRA2BADRA1A | |
| SCHEMBL9070164 | 0.80 | HTR1D (0.56) | HTR1DADRA2CADRA2AADRA2BADRA1A | |
| Hydrochloric Acid SCHEMBL29384552 | 0.79 | HTR1D (0.97) | HTR1DADRA2CADRA2AADRA2BADRA1A | |
| SCHEMBL29374579 | 0.77 | ADRA2C (0.65) | HTR1DADRA2CADRA2AADRA2BADRA1A | |
| SCHEMBL4760243 | 0.77 | HTR1D (1.00) | HTR1DADRA2CADRA2AADRA2BADRA1A | |
| SCHEMBL11218999 | 0.77 | TAAR1 (0.50) | HTR1DADRA2CADRA2AADRA2BADRA1A | |
| Clonidine SCHEMBL18050245 | 0.76 | ADRA2A (0.82) | HTR1DADRA2CADRA2AADRA2BADRA1A | |
| Clonidine SCHEMBL40752 | 0.76 | ADRA2A (1.00) | HTR1DADRA2CADRA2AADRA2BADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230309480-A1 | METHODS OF INCREASING OUTCROSSING RATES IN GRAMINEAE | INTERNATIONAL RICE RESEARCH INSTITUTE (PH) | 2023-10-05 | — | — | US | claimed |
| EP-4199703-A1 | METHODS OF INCREASING OUTCROSSING RATES IN GRAMINEAE | International Rice Research Institute (PH) | 2023-06-28 | — | — | EP | claimed |
| CN-115937332-A | Multi-camera rapid calibration method and three-dimensional calibration object | 江西明天高科技股份有限公司 | 2023-04-07 | — | — | CN | claimed |
| WO-2022038536-A1 | METHODS OF INCREASING OUTCROSSING RATES IN GRAMINEAE | INTERNATIONAL RICE RESEARCH INSTITUTE (PH) | 2022-02-24 | — | — | WO | claimed |
| US-20260127545-A1 | SIMULATION MODEL GENERATION METHOD, SIMULATION MODEL GENERATION PROGRAM, AND SIMULATION MODEL GENERATION SYSTEM | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2026-05-07 | — | — | US | disclosed |
| US-20260079462-A1 | METHOD OF MANAGING MANUFACTURING LINE | KIOXIA CORPORATION (JP) | 2026-03-19 | — | — | US | disclosed |
| US-20260073877-A1 | DISPLAY SUBSTRATE AND DISPLAY APPARATUS | CHENGDU BOE OPTOELECT TECH CO (CN) | 2026-03-12 | — | — | US | disclosed |
| US-20260072513-A1 | Sensory Control Method, Sensory Control System, Method For Generating Conversion Model, Conversion Model Generation System, Method For Converting Relational Expression, And Program | ALPS ALPINE CO LTD (JP) | 2026-03-12 | — | — | US | disclosed |
| WO-2026042565-A1 | AUTHENTICATION SYSTEM, INFORMATION PROCESSING METHOD FOR AUTHENTICATION SYSTEM, AND PROGRAM | フェリカネットワークス株式会社 | 2026-02-26 | — | — | WO | disclosed |
| US-20260057945-A1 | MEMORY SYSTEM | KIOXIA CORPORATION (JP) | 2026-02-26 | — | — | US | disclosed |
| US-12551959-B2 | Solder supply unit, solder piece manufacturing device, part mounting device, and production system | HIRATA CORPORATION (JP) | 2026-02-17 | — | — | US | disclosed |
| US-20260045791-A1 | ELECTRICAL LINE SELECTOR SYSTEM HAVING MULTIPLE SOURCES | RELECTRIFY HOLDINGS PTY LTD (AU) | 2026-02-12 | — | — | US | disclosed |
| CN-114364944-A | Navigation system, route setting device, route setting method, program, and storage medium | 本田技研工业株式会社 | 2022-04-15 | — | — | CN | disclosed |
| US-11281914-B2 | Vehicle monitoring system and vehicle monitoring method | PANASONIC I-PRO SENSING SOLUTIONS CO., LTD. (JP) | 2022-03-22 | — | — | US | disclosed |
| CN-114203223-A | Magnetic storage device and storage system | 铠侠股份有限公司 | 2022-03-18 | — | — | CN | disclosed |
| US-20220084574-A1 | MAGNETIC MEMORY DEVICE AND MEMORY SYSTEM | KIOXIA CORPORATION (JP) | 2022-03-17 | — | — | US | disclosed |
| WO-2022038536-A1 | METHODS OF INCREASING OUTCROSSING RATES IN GRAMINEAE | INTERNATIONAL RICE RESEARCH INSTITUTE (PH) | 2022-02-24 | — | — | WO | disclosed |
| CN-109389602-B | Ceiling map construction method, ceiling map construction device, and ceiling map construction program | 本田技研工业株式会社 | 2022-02-11 | — | — | CN | disclosed |
| US-11230524-B2 | Myocyte enhancer factor 2 (MEF2) modulators | STANDARD LLC (US) | 2022-01-25 | — | — | US | disclosed |
| US-3969525-A | 2-(2',6'-DIETHYLPHENYL-AMINO)-1,3-DIAZACYCLOPENTENE(2) | BOEHRINGER INGELHEIM GMBH (DT) | 1976-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11230524-B2 | Myocyte enhancer factor 2 (MEF2) modulators | MEF2D, MYLK2, TNNT2 | HTR1D 3441/4885ADRA2C 713/4885ADRA2A 789/4885 |
| US-20260073877-A1 | DISPLAY SUBSTRATE AND DISPLAY APPARATUS | GOPC, PTPN14, PTPN4 | HTR1D 2764/4885ADRA2C 3164/4885ADRA2A 3990/4885 |
| US-20260057945-A1 | MEMORY SYSTEM | CACNA1S, CACNA1C, CACNA1E | HTR1D 1120/4885ADRA2C 1914/4885ADRA2A 2689/4885 |
| US-20260072513-A1 | Sensory Control Method, Sensory Control System, Method For Generating Conversion Model, Conversion Model Generation System, Method For Converting Relational Expression, And Program | TRRAP, PIEZO1, L1CAM | HTR1D 768/4885ADRA2C 1371/4885ADRA2A 1824/4885 |
| US-20260127545-A1 | SIMULATION MODEL GENERATION METHOD, SIMULATION MODEL GENERATION PROGRAM, AND SIMULATION MODEL GENERATION SYSTEM | ATP5PO, TIMM44, IPO11 | HTR1D 2113/4885ADRA2C 2771/4885ADRA2A 2387/4885 |
| US-12551959-B2 | Solder supply unit, solder piece manufacturing device, part mounting device, and production system | WAPL, CUTA, LANCL2 | HTR1D 4238/4885ADRA2C 4811/4885ADRA2A 4516/4885 |
| US-20260079462-A1 | METHOD OF MANAGING MANUFACTURING LINE | MOK, THPO, MRPL9 | HTR1D 4210/4885ADRA2C 4197/4885ADRA2A 3170/4885 |
| US-20260045791-A1 | ELECTRICAL LINE SELECTOR SYSTEM HAVING MULTIPLE SOURCES | MCU, SET, PC | HTR1D 4755/4885ADRA2C 3053/4885ADRA2A 3229/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.